English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

HCN channel-mediated neuromodulation can control action potential velocity and fidelity in central axons

MPS-Authors
/persons/resource/persons182611

Trevisiol,  A.
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182201

Hirrlinger,  J.
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

Byczkowicz+19_Elife_.pdf
(Publisher version), 4MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Byczkowicz, N., Eshra, A., Montanaro, J., Trevisiol, A., Hirrlinger, J., Kole, M., et al. (2019). HCN channel-mediated neuromodulation can control action potential velocity and fidelity in central axons. eLife, 8: 42766. doi:10.7554/eLife.42766.


Cite as: https://hdl.handle.net/21.11116/0000-000A-D162-B
Abstract
Hyperpolarization-activated cyclic-nucleotide-gated (HCN) channels control electrical
rhythmicity and excitability in the heart and brain, but the function of HCN channels at the
subcellular level in axons remains poorly understood. Here, we show that the action potential
conduction velocity in both myelinated and unmyelinated central axons can be bidirectionally
modulated by a HCN channel blocker, cyclic adenosine monophosphate (cAMP), and
neuromodulators. Recordings from mouse cerebellar mossy fiber boutons show that HCN channels
ensure reliable high-frequency firing and are strongly modulated by cAMP (EC50 40 mM; estimated
endogenous cAMP concentration 13 mM). In addition, immunogold-electron microscopy revealed
HCN2 as the dominating subunit in cerebellar mossy fibers. Computational modeling indicated that
HCN2 channels control conduction velocity primarily by altering the resting membrane potential
and are associated with significant metabolic costs. These results suggest that the cAMP-HCN
pathway provides neuromodulators with an opportunity to finely tune energy consumption and
temporal delays across axons in the brain.